Identification of Long Noncoding RNAs Expression Profiles Between Gallstone and Gallbladder Cancer Using Next-Generation Sequencing Analysis
Qiang Wang,Pinduan Bi,Ding Luo,Pingli Cao,Weihong Chen,Bin Yang
DOI: https://doi.org/10.2147/ijgm.s442379
IF: 2.145
2024-05-25
International Journal of General Medicine
Abstract:Qiang Wang, &ast Pinduan Bi, &ast Ding Luo, Pingli Cao, Weihong Chen, Bin Yang Department of Hepatobiliary Surgery, the First Affiliated Hospital of Kunming Medical University, Kunming, People's Republic of China &astThese authors contributed equally to this work Correspondence: Bin Yang, Department of Hepatobiliary Surgery, the First Affiliated Hospital of Kunming Medical University, No. 295, Xichang Road, Wuhua District, Kunming, People's Republic of China, Tel +86 013987642890, Email Background: Gallstone disease (GS) is an important risk factor for Gallbladder cancer (GBC). However, the mechanisms of the progression of GS to GBC remain unclear. Long non-coding RNA (lncRNA), modulates DNA/RNA/proteins at epigenetic, pre-transcriptional, transcriptional and posttranscriptional levels, and plays a potential therapeutic role in various diseases. This study aims to identify lncRNAs that have a potential impact on GS-promoted GBC progression. Methods and Results: Six GBC patients without GS, six normal gallbladder tissues, nine gallstones and nine GBC patients with GS were admitted to our hospital. The next-generation RNA-sequencing was performed to analyze differentially expressed (DE) lncRNA and messenger RNA (mRNA) in four groups. Then overlapping and specific molecular signatures were analyzed. We identified 29 co-DEGs and 500 co-DElncRNAs related to gallstone or GBC. The intersection and concatenation of co-DEGs and co-DElncRNA functionally involved in focal adhesion, Transcriptional misregulation in cancers, Protein digestion and absorption, and ECM-receptor interaction signaling pathways may contribute to the development of gallbladder cancer. Further exploration is necessary for early diagnosis and the potential treatment of GBC. FXYD2, MPZL1 and PAH were observed in both co-DEGs and co-DElncRNA and validated by qRT-PCR. Conclusion: Our data identified a series of DEGs and DElncRNAs, which were involved in the progression of GBC and GS-related metabolism pathways. Compared to GBC, the GS profile was more similar to para-tumor tissues in transcriptome level and lower risk of cancer. Further exploration is necessary from GBC patients with different periods of follow-up gallstone. Keywords: gallstone, gallbladder cancer, long non-coding RNA, next-generation sequencing analysis, computational biology Gallbladder cancer (GBC) is the most common malignant tumor of the biliary system (accounting for 80–95%). 1 It is the sixth most common malignant tumor of the digestive tract and occurs three to four times as frequently in women as in men. 2 Gallbladder cancer is relatively high in Latin America and Asia. 3 GBC is not sensitive to radiotherapy and chemotherapy. 1,4 There is currently no recognized chemotherapy regimen that can effectively treat gallbladder cancer. 5 Once the tumor metastasizes or recurs after surgery, doctors are helpless and cannot effectively achieve effective treatment through comprehensive treatment. Gallbladder cancer patients have an extremely poor prognosis. 6 Therefore, the patients would benefit from an early and accurate diagnosis of gallbladder cancer. Due to the lack of specific clinical manifestations of gallbladder cancer, and no other highly specific auxiliary examination methods, most patients are already at the advanced stage of gallbladder cancer due to tumor progression when they are first diagnosed, and they lose the opportunity for radical surgery. 7 Mostly, GBC is diagnosed incidentally in patients undergoing cholecystectomy for the treatment of cholecystitis or cholelithiasis. 8 Epidemiological and pathological evidence confirms that gallstone (GS) patients are more susceptible to GBC than healthy individuals. Based on this, exploring the molecular signatures between GBC and GS could help to understand the molecular mechanism of the progression of GS to GBC, and to find highly specific biomarkers and effective drug treatment targets for GBC, which is beneficial to the development of therapeutic drugs for gallbladder cancer. The occurrence and progression of tumors is a complex process involving multiple genes and multiple factors. 9 Genetic factors have always been considered to play an important role. 10 Studies in recent years have found that the function of RNA is not only to translate into protein. Many RNAs do not have the function of encoding protein, so-called non-coding RNA (ncRNA). 11 Among them, those with a length> 200 nt are named long non-coding RNA (lncRNA). 12 At the earliest, this type of molecule was mistakenly regarded as a by-product of RNA polymerase II transcription, a "noise" in the genome transcription process, without -Abstract Truncated-
medicine, general & internal